-
1 Comment
Universal Health International Group Holding Limited is currently in a long term downtrend where the price is trading 49.4% below its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.1.
Universal Health International Group Holding Limited's total revenue sank by 44.9% to $587M since the same quarter in the previous year.
Its net income has dropped by 50.9% to $-257M since the same quarter in the previous year.
Finally, its free cash flow grew by 53.1% to $-38M since the same quarter in the previous year.
Based on the above factors, Universal Health International Group Holding Limited gets an overall score of 2/5.
| Industry | Pharmaceutical Retailers |
|---|---|
| Sector | Healthcare |
| Exchange | HK |
| CurrencyCode | HKD |
| ISIN | KYG9302L1106 |
| Market Cap | 101M |
|---|---|
| PE Ratio | 6.3 |
| Target Price | 3.44 |
| Beta | -0.48 |
| Dividend Yield | None |
Universal Health International Group Holding Limited, an investment holding company, distributes and retails drugs, healthcare products, and other pharmaceutical products in the northeastern region of the People's Republic of China. Its product categories include Chinese patent medicines, chemical preparations, antibiotics and biochemical drugs, traditional Chinese medicine decoction pieces, biological products, protein assimilation preparations, peptide hormones, disinfection products, blood products, medical equipment, prepackaged food, health care products, nutritional food, stereotyped packaging cosmetics, and daily necessities, as well as family planning supplies, such as contraceptives and utensils; and dairy products, including infant formula milk powder. The company also provides storage services. The company was formerly known as Jintian Pharmaceutical Group Limited and changed its name to Universal Health International Group Holding Limited in July 2015. Universal Health International Group Holding Limited was founded in 1998 and is headquartered in Shenyang, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2211.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
